SBIR/STTR Research Award
Monoclonal Antibodies Against T-Regulatory Cells
Award amount
$639,999Program and phase
SBIR · Phase IAward year
2004Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- CANCER THERAPEUTICS LABORATORIES, INC.
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- KS2BU4J2PHE3
- Solicitation number
- PHS2004-2
- Topic code
- Not reported
Research abstract
DESCRIPTION (provided by applicant): Immunotherapy is a powerful therapeutic modality that has great potential for the treatment of cancer. Considering the lack of options which exist for patients with refractory solid tumors, immunotherapy could provid
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
Research funding history
3 SBIR/STTR records share this UEI (2004–2012). Reported award amounts total $3,419,016. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services